As a further support to the notion that ERβ is involved in LQ antitumor activity, data from the literature demonstrate that, in temozolomide-resistant U138 glioma cells, LQ treatment sensitizes cancer cells to drug-induced inhibition of cell proliferation and significantly increases ERβ expression. Here, ESR2 is linked to cancer.